Seroprevalence of SARS-CoV-2-specific antibodies in cancer outpatients in Madrid (Spain): A single center, prospective, cohort study and a review of available data.

BACKGROUND: Coronavirus disease in 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has emerged as a global pandemic. Published data suggests that patients with a history of or active malignancy are at increased risk of infection and developing COVID-19 related complications. To date, the published data has analyzed the seroprevalence of COVID-19 infection in the general population, but not in cancer patients. Here we present the results of prevalence of IgG and IgM antibodies against SARS-CoV-2 in cancer patients from the University Hospital of Torrejón (Torrejón de Ardoz, Madrid, Spain). METHODS: SARS-CoV-2 IgG and IgM antibodies was assessed using a commercially available rapid test (Testsealabs® IgG/IgM Rapid Test Cassette) and collect the result from cancer outpatients who attended the medical oncology consult at University Hospital of Torrejón between June 1st and June 19th, 2020. FINDINGS: We analyzed the serological test results of 229 cancer patients. We estimated an overall seroprevalence (IgG or IgM positive) of 31.4%. The probability of SARS-CoV-2 seropositivity was similar between men and women, type of treatment and cancer stage. The probability of seropositivity was significantly higher in cancer patients with pneumonia compared with cancer patients without pneumonia (Odds Ratio (OR) 7.65 [95% confidence interval (CI) 1,85-31,58]). INTERPRETATION: Our results show a higher rate of SARS-CoV-2 antibodies in cancer patients than in the general population. The role of those antibodies in the immune response against the virus infection is unclear.

Los anticoagulantes orales de acción directa en el tratamiento de la enfermedad tromboembólica venosa asociada a cáncer / Direct oral anticoagulants for the treatment of venous thromboembolism in patients with cancer

No disponible

Relation of Structural and Functional Changes in Auditory and Visual Pathways after Temporal Lobe Epilepsy Surgery.

Auditory and visual pathways may be affected as a consequence of temporal lobe epilepsy surgery because of their anatomical relationships with this structure. The purpose of this paper is to correlate the results of the auditory and visual evoked responses with the parameters of tractography of the visual pathway, and with the state of connectivity between respective thalamic nuclei and primary cortices in both systems after the surgical resection of the epileptogenic zone in drug-resistant epileptic patients. Tractography of visual pathway and anatomical connectivity of auditory and visual thalamus-cortical radiations were evaluated in a sample of eight patients. In general, there was a positive relationship of middle latency response (MLR) latency and length of resection, while a negative correlation was found between MLR latency and the anatomical connection strength and anatomical connection probability of the auditory radiations. In the visual pathway, significant differences between sides were found with respect to the number and length of tracts, which was lower in the operated one. Anatomical connectivity variables and perimetry (visual field defect index) were particularly correlated with the latency of P100 wave which was obtained by quadrant stimulation. These results demonstrate an indirect functional modification of the auditory pathway and a direct traumatic lesion of the visual pathway after anterior temporal lobectomy in patients with drug resistant epilepsy.

Anticoagulantes orales directos: puesta al día / Direct oral anticoagulants: An update

Durante medio siglo los antagonistas de la vitamina K han sido la única opción disponible para la terapia anticoagulante oral. En los últimos años se han desarrollado anticoagulantes orales directos: un inhibidor directo de la trombina (dabigatrán etexilato) y 3 inhibidores directos del factor X activado (rivaroxabán, apixabán y edoxabán). Todos ellos han demostrado un beneficio-riesgo favorable, comparables en eficacia y seguridad a los anticoagulantes tradicionales antagonistas de la vitamina K, en la prevención del ictus y la embolia sistémica en pacientes con fibrilación auricular no valvular, la profilaxis y el tratamiento del tromboembolismo venoso y el síndrome coronario agudo. En 2008 la Agencia Europea del Medicamento aprobó el primer anticoagulante oral directo, dabigatrán. Posteriormente, rivaroxabán, apixabán y edoxabán fueron autorizados. En este artículo se revisa la experiencia acumulada con cada uno de estos fármacos

Vitamin K antagonists were the only choice for chronic oral anticoagulation for more than half a century. Over the past few years, direct oral anticoagulants have emerged, including one direct thrombin inhibitor (dabigatran etexilate) and three factor Xa inhibitors (apixaban, edoxaban and rivaroxaban). In randomised controlled trials comparing direct oral anticoagulants with traditional vitamin K antagonists, the direct oral anticoagulants all showed a favourable benefit-risk balance in their safety and efficacy profile, in prevention of thromboembolic events in patients with atrial fibrillation and in the prevention and treatment of venous thromboembolism and acute coronary syndrome. In 2008, dabigatran was the first direct oral anticoagulant approved by the European Medicine Agency. Subsequently, rivaroxaban, apixaban and edoxaban were also authorised. This article reviews the evidence related to the use of these drugs

Diferencias en pacientes oncológicos y no oncológicos ingresados en una unidad de cuidados paliativos de reciente creación en un hospital de tercer nivel en la Comunidad Valenciana (España) / Differences in cancer patients and non-cancer patients admitted to a new palliative care unit of the general university hospital of the Valencian Community (Spain)

OBJETIVO: Evaluar las diferencias entre pacientes paliativos oncológicos y no oncológicos ingresados en la Unidad de Cuidados Paliativos. MATERIAL Y MÉTODOS: Estudio retrospectivo y analítico de los paciente paliativos atendidos en la Unidad de Cuidados Paliativos perteneciente al Servicio de Medicina Interna del Hospital General Universitario de Alicante entre el 1 junio de 2013 y el 31 de junio del 2014. De cada paciente se recogieron variables epidemiológicas (edad, sexo), clínicas (fiebre, caquexia/anorexia, astenia, náuseas/vómitos, somnolencia, síntomas psicológicos, dolor y disnea), evolutivas y necesidad de sedación paliativa. RESULTADOS: Fueron estudiados en la Unidad de Cuidados Paliativos 143 de los 1.599 (8,9%) ingresados en la sección de medicina interna. La mediana de edad de los paciente fue de 83 años (recorrido intercuartílico: 75-89) y la relación hombre/mujeres fue de 1,4. Sesenta y cuatro (44,7%) ingresos fueron pacientes paliativos oncológicos y 79 (65,3%) no oncológicos. Y dentro de los pacientes no oncológicos estos fueron: 38 (48,1%) pacientes pluripatológicos con progresión irreversible de comorbilidades, 33 (41,8%) (pacientes por enfermedad crónica en estadio final y 8 (10,1%) pacientes de edad avanzada en estadio final de la vida. Respecto a los síntomas hubo una mayor probabilidad de disnea en los pacientes paliativos no oncológicos (odds ratio [OR]: 4,65, intervalo de confianza [IC] 95%: 2,17-10,7) y una menor probabilidad de dolor (OR: 0,23; IC 95%: 0,09-0,54) y náuseas/vómitos (p = 0,025) en ellos. Así como un mayor control de síntomas fue mayor en los pacientes paliativos no oncológicos (OR: 2,03; IC95%: 1,0-4,10). La sedación paliativa fue administrada en el 23% de los casos, similar en los dos grupos de pacientes. CONCLUSIÓN: La sintomatología de los cuidados paliativos es diferente en pacientes no oncológicos y oncológicos

OBJECTIVE: To evaluate patient differences between palliative cancer and non-cancer patients admitted to the Unit of Palliative Care. MATERIAL AND METHODS: A retrospective and analytical study of the palliative patients treated in the Unit of Palliative Care under the Department of Internal Medicine, Hospital General Universitario of Alicante between 1 June 2013 and 31 June 2014. Variables included were epidemiological (age, sex), clinical symptoms (fever, cachexia / anorexia, asthenia, nausea / vomiting, drowsiness, psychological symptoms, pain and dyspnoea), outcome and need for palliative sedation. RESULTS: One hundred and forty-three patients out of the 1,599 (8.9%) admitted to the Section of Internal Medicine were studied in the Unit of Palliative Care. The median age of the patients was 83 years (interquartile range: 75-89) and the male: female ratio was 1.4. Sixty-four (44.7%) were palliative cancer patients and 79 (65.3%) were non-cancer palliative. Out of 79 non-cancer palliative PATIENTS: 38 (48.1%) were patients with irreversible progression of comorbidities, 33 (41.8%) patients with end-stage chronic disease and 8 (10.1%) elderly patients in the final stage of life. With regard to symptoms, the non-cancer palliative patients were more likely to experience dyspnoea (odds ratio [OR]: 4.65, 95% confidence interval [CI]:, 1.7-10 7) and less likely to experience pain (OR: 0.23; 95% CI: 0.09 to 0.54) and nausea /vomiting (p =.025). Symptoms were better controlled in the non- non- cancer palliative patients (OR: 2.03; 95% CI 1.0 to 4.10). Palliative sedation was administered to 23% of the patients, similar in both types of PATIENTS: CONCLUSIONS: The symptoms of palliative care were different in the non-cancer and cancer patients

Long-Term Electroclinical and Employment Follow up in Temporal Lobe Epilepsy Surgery. A Cuban Comprehensive Epilepsy Surgery Program.

The purpose of this paper is to present a long- term electroclinical and employment follow up in temporal lobe epilepsy (TLE) patients in a comprehensive epilepsy surgery program. Forty adult patients with pharmacoresistant TLE underwent detailed presurgical evaluation. Electroencephalogram (EEG) and clinical follow up assessment for each patient were carried out. The occurrence of interictal epileptiform activity (IEA) and absolute spike frequency (ASF) were tabulated before and after 1, 6, 12, 24 and 72 months surgical treatment. Employment status pre- to post-surgery at the last evaluated period was also examined. Engel scores follow-up was described as follows: at 12 months 70% (28) class I, 10% (4) class II and 19% (8) class III-IV; at 24 months after surgery 55.2% (21) of the patients were class I, 28.9% (11) class II and 15.1% (6) class III-IV. After one- year follow up 23 (57.7%) patients were seizure and aura-free (Engel class IA). These figures changed to 47.3%, and 48.6% respectively two and five years following surgery whereas 50% maintained this condition in the last follow up period. A decline in the ASF was observed from the first year until the sixth year after surgery in relation to the preoperative EEG. The ASF one year after surgery allowed to distinguish "satisfactory" from "unsatisfactory" seizure relief outcome at the last follow up. An adequate social functioning in terms of education and employment in more than 50% of the patients was also found. Results revealed the feasibility of conducting a successful epilepsy surgery program with favorable long term electroclinical and psychosocial functioning outcomes in a developing country as well.

Direct oral anticoagulants: An update. / Anticoagulantes orales directos: puesta al día.

Vitamin K antagonists were the only choice for chronic oral anticoagulation for more than half a century. Over the past few years, direct oral anticoagulants have emerged, including one direct thrombin inhibitor (dabigatran etexilate) and three factor Xa inhibitors (apixaban, edoxaban and rivaroxaban). In randomised controlled trials comparing direct oral anticoagulants with traditional vitamin K antagonists, the direct oral anticoagulants all showed a favourable benefit-risk balance in their safety and efficacy profile, in prevention of thromboembolic events in patients with atrial fibrillation and in the prevention and treatment of venous thromboembolism and acute coronary syndrome. In 2008, dabigatran was the first direct oral anticoagulant approved by the European Medicine Agency. Subsequently, rivaroxaban, apixaban and edoxaban were also authorised. This article reviews the evidence related to the use of these drugs.

Clinical Case of Metastatic Adrenocortical Carcinoma With Unusual Evolution: Review the Literature.

Adrenocortical carcinoma (ACC) is a rare and heterogeneous malignancy, with an incidence of approximately 0.72 per million cases per year leading to 0.2% of all cancer deaths in the United States. Metastatic ACC has a dismal prognosis with an overall survival of less than 1 year. We present a case of a 37-year-old man with metastatic ACC with unusual good prognosis and review the therapeutic options in the literature.

Correlación entre la memoria subjetiva y objetiva episódica en pacientescon epilepsia del lóbulo temporal medial intratable / Correlation between subjective memory and episodic objective memory in patients with intractable medial temporal lobe epilepsy

Introducción. En la literatura científica revisada prevalece una discordancia en las investigaciones sobre la relación entre la memoria subjetiva y objetiva en pacientes con Epilepsia del Lóbulo Temporal medial intratable (ELTmi). Objetivo. Identificar la existencia o no de relación entre la memoria subjetiva y objetiva episódica en pacientes con ELTmi. Metodología. Se estudiaron 32 pacientes, con edades entre 15 y 60 años, empleándose el método clínico. Se aplicó una entrevista semiestructurada, el Cuestionario de Eficiencia de Memoria; el Test de aprendizaje verbal-auditivo de Rey y el Test de reproducción y copia de la figura compleja de Rey-Osterreith. Se realizó el procesamiento de los datos obtenidos. Resultados. Los pacientes reportaron quejas sobre su memoria. La modalidad viso-perceptual se mostró preservada, no así en la verbal-auditiva. No existieron diferencias en función de la lateralización de la zona de inicio ictal para ambas modalidades. Se evidenció una correlación negativa entre la memoria subjetiva y la estabilidad de la huella (modalidad verbal-auditiva). Los pacientes con lateralización izquierda mostraron correlación positiva entre la memoria subjetiva y el recuerdo demorado (modalidad viso-perceptual). Conclusiones. Los pacientes mostraron afectación de la memoria subjetiva, independientemente de la lateralización. También revelaron un perfil heterogéneo en la memoria objetiva episódica; así como la existencia de relación entre la memoria subjetiva y la objetiva episódica en la estabilidad de la huella (modalidad verbal-auditiva) y el recuerdo demorado (modalidad viso-perceptual) solo en los pacientes con lateralización izquierda.

Introduction. In the scientific literature there is not agreement about the existence of relationship between subjective memory and the episodic objective memory in untreatable medial temporal lobe epileptic patients (UMTLE). Objective. To identify the presence of relationship between subjective memory and the episodic objective memory in UMTLE patients. Methods. We studied 32 patients, aged 15-60; all of them were interviewed using a semiestructured interview model and a Questionnaire of Memory Efficiency; the Rey´s Auditory Verbal Learning Test and the Reproduction and copy of complex figure Rey-Osterreith. Test data were analyzed. Results. Patients complained about their memory, viso-perceptual modality was preserved but verbal-auditive modality did not. We didnot find any differences related to the lateralization of the ictal zone for both modalities. There was a negative correlation between the subjective memory and the verbal-auditive modality. Patients with left side lateralization showed a positive correlation between the subjective memory and the delayed viso-perceptual memory type. Conclusions. Patients had abnormalities in the subjective memory unrelated to the lateralization. They also had an heterogeneous profile in the episodic memory and the existence of relationship between subjective memory and the episodic objective memory (verbal-auditive), and a delayed visoperceptual memory type only in patients with left lateralization.

[Mortality and prognostic factors in patients admitted with community-acquired bacteremia]. / Mortalidad y factores pronósticos en pacientes hospitalizados por bacteriemia adquirida en la comunidad.

BACKGROUND: Community-acquired bacteremia is a frequently clinical problem and is associated with a high mortality. The Pitt bacteremia score that is calculated using body temperature, mental status, and some respiratory and circulatory features is an useful tool in order to know the prognosis of patients with bacteremia. Objectives were to know microbial etiology of bacteremia in our community, percentage of patients that received an inadequate empiric antibiotic treatment and independent prognostic factors associated with mortality, including Pitt bacteremia score. METHOD: Observational study of a cohort of patients over 18 years admitted at a tertiary hospital due to an infection with a community-acquired bacteremia. Twenty-eight cases were rejected because possible blood culture contamination. RESULTS: Seventy-five patients were included, the mean age was 68.6 +/- 18.2 years, 38 women (51%). Mortality rate was 23% [IC95% 13.8-33.8]. More frequent bacteria isolated were Escherichia coli, Staphylococcus aureus, coagulase negative staphylococci, Pseudomonas aeruginosa, Streptococcus viridans, enterococci and Klebsiella spp. Mortality in patients treated with an inadequate antibiotic therapy (18%, 3 patients) was not lower than in adequately treated patients (24%, 14 patients, p = 0.42). Independent prognostic factors related to mortality were serum albumin concentration, OR = 5.17 (IC 95% 1.45-16.7) for every downing step of 1 g/dl, the Pitt bacteremia score OR = 1.50 (IC 95% 1.01-2.24) for every unit increase, and a high score at McCabe and Jackson classification OR = 5.08 ( IC 95% 1.43-16.7). CONCLUSIONS: An inadequate empiric antibiotic therapy was not associated with a worse vital prognosis. Independent prognostic factors related to mortality were serum albumin concentration, the Pitt bacteremia score, and the McCabe and Jackson classification.

Fiebre sin foco y trasplante hepático: infección por virus del herpes humano tipo 6 en pacientes trasplantados / Fever without an infectious focus and liver transplantation: Infection due to human herpes virus type 6 in transplanted patients

No disponible

Psicosis interictal: presentación de un caso / Interictal psychosis: presentation of the case

La psicosis epiléptica es un tema debatido desde hace más de medio siglo. La clasificación de Ponds publicada en 1957 aún tiene vigencia con algunas modificaciones, a nuestro juicio, porque relaciona los numerosos síntomas de una entidad tan estudiada como controvertida, de manera que quedan implicados y en la práctica se observa, más que una co-morbilidad psiquiátrica, un cuadro que requiere de cuidadosos estudios clínicos. Dicha clasificación agrupa las manifestaciones psiquiátricas en trastornos ictales, trastornos interictales, y trastornos postictales. Los trastornos ictales están tan relacionados con la semiología de la epilepsia pues son las manifestaciones de toma de conciencia que se producen en el ictus. Los trastornos interictales se ajustan al período intercrisis donde una serie de entidades psiquiátricas concomitantes con la epilepsia se presentan, y la controvertida personalidad epiléptica se enuncia. Los trastornos posictales son considerados de uno a dos días del ictus. En la práctica, la clásica pregunta de si es orgánico o funcional un cuadro sintomático, está tan interiorizado en el quehacer médico que aunque hayamos conceptualizado un diagnóstico, los criterios dualistas y de sindromología nos lleva frecuentemente a la duda. La presentación del caso de una joven de 19 años que asiste para que sea precisado su diagnóstico con un cortejo de síntomas y signos psiquiátricos, su evolución durante un año y tratamiento así como consideraciones etiológicas son los objetivos de este trabajo(AU)